Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 1:04 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 169–192 of 1,578 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Arrhythmias Cardiac Clear all

Conditions: Atrial Fibrillation
Interventions: Rivaroxaban (Xarelto, BAY59-7939), VKA (Vitamin K antagonist); Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years and older
Enrollment: 38,831 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016
U.S. locations: 1
States / cities: New York, New York

Conditions: Bradycardia, Sinus Node Dysfunction
Interventions: INGEVITY lead; Device
Lead sponsor: Boston Scientific Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 1,060 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2019
U.S. locations: 44
States / cities: Gilbert, Arizona • Glendale, Arizona • Tucson, Arizona + 39 more

Conditions: Cardiac Arrhythmia
Interventions: Electrophysiology procedure; Device
Lead sponsor: CathVision ApS; Industry
Eligibility: 18 Years and older
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Burlington, Vermont

Conditions: Tachyarrhythmias, Sudden Cardiac Death, Heart Failure
Interventions: SJ4 connector and RV high voltage SJ4 lead; Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 1,701 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2015
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Ventricular Tachycardia, Ischemic Cardiomyopathy
Interventions: Ablation-index guided ventricular tachycardia ablation, Ventricular tachycardia ablation with no AI-guidance; Procedure
Lead sponsor: Rush University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 5
States / cities: Chicago, Illinois • Boston, Massachusetts • Ann Arbor, Michigan + 2 more

Conditions: Atrial Fibrillation, Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation
Interventions: OPC-108459, Placebo; Drug
Lead sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 9
States / cities: Washington D.C., District of Columbia • Hollywood, Florida • Jacksonville, Florida + 6 more

Conditions: Paroxysmal Atrial Fibrillation
Interventions: Atrial fibrillation catheter ablation using the Medtronic Arctic Front Ablation System; Procedure
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 2
States / cities: San Francisco, California • Seattle, Washington

Conditions: Atrial Fibrillation, Obesity and Obesity-related Medical Conditions
Interventions: Roux-en-Y Gastric Bypass or Sleeve Gastrectomy, Anti-Obesity Medication (AOM) treatment; Procedure · Drug
Lead sponsor: Ali Aminian; Other
Eligibility: 18 Years to 80 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Atrial Fibrillation
Interventions: Not listed
Lead sponsor: Baylor Research Institute; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Plano, Texas

Conditions: Persistent Atrial Fibrillation
Interventions: TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™; Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 224 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 20
States / cities: Birmingham, Alabama • Jonesboro, Arkansas • Little Rock, Arkansas + 17 more

Conditions: Cardiac Arrhythmias, Heart Failure
Interventions: Control, QuickOpt; Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 1,647 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 2
States / cities: Los Angeles, California • Columbus, Ohio

Conditions: Arrhythmia, Cardiac
Interventions: recorded patients; Other
Lead sponsor: NewPace Ltd; Industry
Eligibility: Not listed
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Atlantis, Florida

Conditions: Atrial Fibrillation
Interventions: triiodothyronine; Drug
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years to 85 Years
Enrollment: 280 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Manhasset, New York

Conditions: Ventricular Tachycardia
Interventions: TcMS; Device
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Bradycardia
Interventions: St. Jude Medical Tendril MRI™ lead; Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 1,768 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 66
States / cities: Phoenix, Arizona • Jonesboro, Arkansas • Little Rock, Arkansas + 62 more

Conditions: Cardioversion
Interventions: Blood sample collection; Diagnostic Test
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 104 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Atrial Fibrillation
Interventions: Numeris-AF Tethered Coagulation System with VisiTrax; Device
Lead sponsor: nContact Surgical Inc.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 2
States / cities: Venice, Florida • Memphis, Tennessee

Conditions: Cardiotoxicity, Cancer, Cardiac Arrhythmia, Left Ventricular Dysfunction, Breast Cancer, Multiple Myeloma
Interventions: Mobile Cardiac Telemetry, Wearable Cardiac Monitor; Device
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years and older
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Atrial Fibrillation
Interventions: Warfarin, Apixaban; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 220,518 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Arrhythmias, Cardiac, Atrial Fibrillation, Atrial Flutter, Bradycardia, Tachycardia
Interventions: Vectorcardiography (VECG); Device
Lead sponsor: HeartBeam, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 198 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 5
States / cities: Atlanta, Georgia • Tucker, Georgia • New York, New York + 2 more

Conditions: Atrial Fibrillation
Interventions: Pulmonary vein antrum isolation (PVAI), PVAI plus left atrial posterior wall (LAPW) isolation; Procedure
Lead sponsor: Texas Cardiac Arrhythmia Research Foundation; Other
Eligibility: 18 Years and older
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Atrial Fibrillation
Interventions: Investigational Device (Withings SCT02) 30 second Electrocardiogram recording, Reference Device (Schiller Cardiovit FT-1) 30 second Electrocardiogram recording; Device
Lead sponsor: Withings; Industry
Eligibility: 22 Years and older
Enrollment: 373 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 2
States / cities: Boca Raton, Florida • Miami, Florida

Conditions: Arrhythmias, Cardiac
Interventions: Electromechanical wave imaging (EWI); Diagnostic Test
Lead sponsor: Columbia University; Other
Eligibility: 18 Years and older
Enrollment: 322 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: New York, New York

Conditions: Long QT Syndrome
Interventions: GS-6615; Drug
Lead sponsor: Gilead Sciences; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Rochester, New York

Search by objective public record fields.

Real-world Comparative Effectiveness of Rivaroxaban Versus VKA

Safety and Performance Study of the INGEVITY Lead

An Evaluation of the Safety and Performance of the CathVision ECGenius® System.

SJ4 Post Approval Study in Implantable Cardioverter-Defibrillator and Cardiac Resynchronization Therapy Defibrillator Patients

Ablation-Index Guided Scar-Mediated Ventricular Tachycardia Ablation in Patients With Ischemic Cardiomyopathy

Ascending Dose Study of OPC-108459 Intravenous Infusions in Patients With Paroxysmal and Persistent Atrial Fibrillation

The OneFreeze Study

Metabolic Surgery for Atrial Fibrillation Elimination

Proper Extent of Maze Intercaval Lesion

Safety and Effectiveness of TactiCath™ Contact Force, Sensor Enabled™ (TactiCath SE) Catheter for Ablation of Drug Refractory, Symptomatic, Persistent Atrial Fibrillation

FREEDOM - A Frequent Optimization Study Using the QuickOpt Method

Surface Electrocardiogram (ECG) Signal Recording for Implantable Subcutaneous String Defibrillator (ISSD) Development

Study of T3 on the Incidence of Atrial Fibrillation in Patients Undergoing Cardiac Surgery

TcMS to Treat Ventricular Tachycardia

SJM Brady MRI Post Approval Study

Myocardial Injury Following Elective Direct Current Cardioversion for Atrial Arrhythmias

nContactSurgical Numeris-AF Tethered Coagulation System for Treatment of Persistent & LSP AF

Monitoring for CardioToxicity Using WeArable deVices While Undergoing cancEr Treatments (MCT-WAVE)

Replication of the ARISTOTLE Anticoagulant Trial in Healthcare Claims Data

AIMIGo 12L ECG Synthesis Software Pivotal Study for Arrythmia Detection

Outcome of Atrial Fibrillation Ablation After Permanent Pulmonary Vein Antrum Isolation With or Without Proven Left Atrial Posterior Wall Isolation

WIBOFA - Validation of SCT02 With ECG-App for Detection of AF

Ablation Guided Via Precision Imaging Using Electromechanical Wave Imaging

Study of the Effect of GS-6615 in Subjects With LQT-3